{"slug":"ghsg","tag":"ghsg","variants":["ghsg"],"description":"No description yet","count":2,"kinds":{"person":2},"related":[{"slug":"hodgkin","tag":"hodgkin","shared":2},{"slug":"de-escalation","tag":"de-escalation","shared":1},{"slug":"trialist","tag":"trialist","shared":1}],"records":[{"id":"peter-borchmann","kind":"person","name":"Peter Borchmann","route":"/people/peter-borchmann/","tldr":"Leads the German Hodgkin Study Group and HD21, which made BrECADD the most effective and least toxic regimen for advanced Hodgkin lymphoma."},{"id":"andreas-engert","kind":"person","name":"Andreas Engert","route":"/people/andreas-engert/","tldr":"Led the GHSG for two decades, running the HD10 to HD18 trials that cure over 90% of Hodgkin lymphoma with less treatment."}]}